Q BioMed Inc (QBIO)
0.0005
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Q BioMed Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 9.323M |
| May 02, 2024 | 9.323M |
| May 01, 2024 | 9.323M |
| April 30, 2024 | 9.279M |
| April 29, 2024 | 9.279M |
| April 26, 2024 | 9.279M |
| April 25, 2024 | 9.279M |
| April 24, 2024 | 9.279M |
| April 23, 2024 | 9.279M |
| April 22, 2024 | 9.279M |
| April 19, 2024 | 9.279M |
| April 18, 2024 | 9.279M |
| April 17, 2024 | 9.265M |
| April 16, 2024 | 9.265M |
| April 15, 2024 | 9.250M |
| April 12, 2024 | 9.250M |
| April 11, 2024 | 9.250M |
| April 10, 2024 | 9.250M |
| April 09, 2024 | 9.250M |
| April 08, 2024 | 9.250M |
| April 05, 2024 | 9.250M |
| April 04, 2024 | 9.250M |
| April 03, 2024 | 9.294M |
| April 02, 2024 | 9.294M |
| April 01, 2024 | 9.294M |
| Date | Value |
|---|---|
| March 28, 2024 | 9.294M |
| March 27, 2024 | 9.294M |
| March 26, 2024 | 9.294M |
| March 25, 2024 | 9.294M |
| March 22, 2024 | 9.294M |
| March 21, 2024 | 9.294M |
| March 20, 2024 | 9.279M |
| March 19, 2024 | 9.279M |
| March 18, 2024 | 9.279M |
| March 15, 2024 | 9.279M |
| March 14, 2024 | 9.250M |
| March 13, 2024 | 9.250M |
| March 12, 2024 | 9.250M |
| March 11, 2024 | 9.250M |
| March 08, 2024 | 9.250M |
| March 07, 2024 | 9.250M |
| March 06, 2024 | 9.294M |
| March 05, 2024 | 9.279M |
| March 04, 2024 | 9.279M |
| March 01, 2024 | 9.265M |
| February 29, 2024 | 9.265M |
| February 28, 2024 | 9.265M |
| February 27, 2024 | 9.265M |
| February 26, 2024 | 9.279M |
| February 23, 2024 | 9.265M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.250M
Minimum
Nov 22 2023
71.51M
Maximum
Feb 20 2020
22.28M
Average
20.10M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.813M |
| Palatin Technologies Inc | 24.56M |
| iBio Inc | 16.80M |
| Theriva Biologics Inc | -13.31M |
| Oragenics Inc | 3.216M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.7216M |
| Total Expenses (Quarterly) | 0.445M |
| EPS Diluted (Quarterly) | -0.02 |